Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000982440 | SCV001130455 | likely benign | not provided | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002489450 | SCV002799861 | likely benign | Bone mineral density quantitative trait locus 1; Exudative vitreoretinopathy 4; Exudative vitreoretinopathy 1; Worth disease; Autosomal dominant osteopetrosis 1; Osteoporosis with pseudoglioma; Osteoporosis; Polycystic liver disease 4 with or without kidney cysts | 2021-08-16 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000982440 | SCV002033966 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000982440 | SCV002038417 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003962953 | SCV004785682 | likely benign | LRP5-related disorder | 2022-09-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |